Spots Global Cancer Trial Database for radiomammography
Every month we try and update this database with for radiomammography cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer | NCT00516698 | Breast Cancer | polymorphism an... high performanc... laboratory biom... radiomammograph... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer | NCT00516698 | Breast Cancer | polymorphism an... high performanc... laboratory biom... radiomammograph... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Effect of 4-Hydroxytamoxifen Gel on Breast Density, Salivary Sex Steroids, and Quality of Life in Premenopausal Women | NCT00084344 | Breast Cancer | 4-hydroxytamoxi... breast imaging ... radiomammograph... | 30 Years - 50 Years | Northwestern University | |
| Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery | NCT00033397 | Breast Cancer | biopsy magnetic resona... radiomammograph... ultrasound imag... gadopentetate d... chemotherapy | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Effect of 4-Hydroxytamoxifen Gel on Breast Density, Salivary Sex Steroids, and Quality of Life in Premenopausal Women | NCT00084344 | Breast Cancer | 4-hydroxytamoxi... breast imaging ... radiomammograph... | 30 Years - 50 Years | Northwestern University | |
| Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery | NCT00665457 | Breast Cancer | filgrastim capecitabine celecoxib cyclophosphamid... docetaxel doxorubicin hyd... gene expression... polymorphism an... protein express... reverse transcr... imaging biomark... immunohistochem... laboratory biom... pharmacogenomic... dynamic contras... needle biopsy neoadjuvant the... radiomammograph... ultrasound imag... | 19 Years - 120 Years | University of Nebraska | |
| Changes in Breast Density and Breast Cancer Risk in Women With Breast Cancer and in Healthy Women | NCT00445445 | Breast Cancer | physiologic tes... screening quest... breast imaging ... radiomammograph... study of high r... | 40 Years - | Case Comprehensive Cancer Center | |
| Computer-Aided Breast Cancer Detection in Women Undergoing Screening Mammography | NCT00450359 | Breast Cancer | breast imaging ... comparison of s... radiomammograph... | 50 Years - 70 Years | National Cancer Institute (NCI) | |
| Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery | NCT00665457 | Breast Cancer | filgrastim capecitabine celecoxib cyclophosphamid... docetaxel doxorubicin hyd... gene expression... polymorphism an... protein express... reverse transcr... imaging biomark... immunohistochem... laboratory biom... pharmacogenomic... dynamic contras... needle biopsy neoadjuvant the... radiomammograph... ultrasound imag... | 19 Years - 120 Years | University of Nebraska | |
| Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery | NCT00033397 | Breast Cancer | biopsy magnetic resona... radiomammograph... ultrasound imag... gadopentetate d... chemotherapy | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Breast Ultrasound and Mammography in Screening Women at High Risk for Breast Cancer | NCT00072501 | Breast Cancer | breast imaging ... comparison of s... magnetic resona... radiomammograph... ultrasound imag... | 25 Years - | National Cancer Institute (NCI) | |
| Breast Ultrasound and Mammography in Screening Women at High Risk for Breast Cancer | NCT00072501 | Breast Cancer | breast imaging ... comparison of s... magnetic resona... radiomammograph... ultrasound imag... | 25 Years - | National Cancer Institute (NCI) | |
| Breast Ultrasound and Mammography in Screening Women at High Risk for Breast Cancer | NCT00072501 | Breast Cancer | breast imaging ... comparison of s... magnetic resona... radiomammograph... ultrasound imag... | 25 Years - | National Cancer Institute (NCI) | |
| MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ | NCT00874458 | Breast Cancer | magnetic resona... radiomammograph... ultrasound imag... | 18 Years - | Centre Antoine Lacassagne | |
| MRI in Evaluating Early Response to Chemotherapy in Women Receiving Chemotherapy for Infiltrating Breast Cancer | NCT00462696 | Breast Cancer | docetaxel epirubicin hydr... conventional su... dynamic contras... neoadjuvant the... radiomammograph... | 18 Years - 70 Years | National Cancer Institute (NCI) | |
| Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease | NCT00813878 | Breast Cancer | protein analysi... protein express... proteomic profi... diagnostic labo... immunohistochem... liquid chromato... mass spectromet... fine-needle asp... needle biopsy radiomammograph... | 18 Years - 120 Years | City of Hope Medical Center | |
| MRI in Evaluating Early Response to Chemotherapy in Women Receiving Chemotherapy for Infiltrating Breast Cancer | NCT00462696 | Breast Cancer | docetaxel epirubicin hydr... conventional su... dynamic contras... neoadjuvant the... radiomammograph... | 18 Years - 70 Years | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
